MITO Annual CFF
$59.14 M
+$23.52 M+66.03%
31 December 2021
Summary:
As of February 5, 2025, MITO annual cash flow from financing activities is $59.14 million, with the most recent change of +$23.52 million (+66.03%) on December 31, 2021. During the last 3 years, it has fallen by -$19.69 million (-24.98%).MITO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MITO Quarterly CFF
N/A
31 March 2022
Summary:
MITO quarterly cash flow from financing activities is not available.MITO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MITO TTM CFF
N/A
31 March 2022
Summary:
MITO TTM cash flow from financing activities is not available.MITO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MITO Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +66.0% | - | - |
| 3 y3 years | -25.0% | - | - |
| 5 y5 years | -8.2% | - | - |
MITO Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -32.8% |
Stealth BioTherapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $59.14 M(+66.0%) | - | - |
| June 2021 | - | $21.01 M(+61.8%) | $34.00 M(+26.1%) |
| Dec 2020 | $35.62 M(-59.5%) | - | - |
| Sept 2020 | - | $12.99 M(-7.1%) | $26.97 M(-71.2%) |
| June 2020 | - | $13.98 M | $93.80 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $88.03 M(+11.7%) | - | - |
| Sept 2019 | - | $79.82 M(+56.9%) | $79.82 M(+56.9%) |
| Dec 2018 | $78.83 M(+22.4%) | - | - |
| Sept 2018 | - | $50.89 M | $50.89 M |
| Dec 2017 | $64.42 M(+28.1%) | - | - |
| Dec 2016 | $50.29 M | - | - |
FAQ
- What is Stealth BioTherapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Stealth BioTherapeutics?
- What is Stealth BioTherapeutics annual CFF year-on-year change?
- What is the all time high quarterly CFF for Stealth BioTherapeutics?
- What is the all time high TTM CFF for Stealth BioTherapeutics?
What is Stealth BioTherapeutics annual cash flow from financing activities?
The current annual CFF of MITO is $59.14 M
What is the all time high annual CFF for Stealth BioTherapeutics?
Stealth BioTherapeutics all-time high annual cash flow from financing activities is $88.03 M
What is Stealth BioTherapeutics annual CFF year-on-year change?
Over the past year, MITO annual cash flow from financing activities has changed by +$23.52 M (+66.03%)
What is the all time high quarterly CFF for Stealth BioTherapeutics?
Stealth BioTherapeutics all-time high quarterly cash flow from financing activities is $79.82 M
What is the all time high TTM CFF for Stealth BioTherapeutics?
Stealth BioTherapeutics all-time high TTM cash flow from financing activities is $93.80 M